BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8781784)

  • 1. Inactivation of cytochrome P4502B1 by the monoamine oxidase inhibitors R-(-)-deprenyl and clorgyline.
    Sharma U; Roberts ES; Hollenberg PF
    Drug Metab Dispos; 1996 Jun; 24(6):669-75. PubMed ID: 8781784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formation of a metabolic intermediate complex of cytochrome P4502B1 by clorgyline.
    Sharma U; Roberts ES; Hollenberg PF
    Drug Metab Dispos; 1996 Nov; 24(11):1247-53. PubMed ID: 8937860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic inactivation of cytochrome P4502B1 by phencyclidine: immunochemical and radiochemical analyses of the protective effects of glutathione.
    Sharma U; Roberts ES; Kent UM; Owens SM; Hollenberg PF
    Drug Metab Dispos; 1997 Feb; 25(2):243-50. PubMed ID: 9029055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of rat liver microsomal CYP1A2 and CYP2B1 activity by N-(2-heptyl)-N-methyl-propargylamine and by N-(2-heptyl)-propargylamine.
    Dyck LE; Davis BA
    Drug Metab Dispos; 2001 Aug; 29(8):1156-61. PubMed ID: 11454735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism-based inactivation of rat liver cytochrome P4502B1 by phencyclidine and its oxidative product, the iminium ion.
    Crowley JR; Hollenberg PF
    Drug Metab Dispos; 1995 Aug; 23(8):786-93. PubMed ID: 7493543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism-based inactivation of cytochrome P450 2B1 by N-benzyl-1-aminobenzotriazole.
    Kent UM; Bend JR; Chamberlin BA; Gage DA; Hollenberg PF
    Chem Res Toxicol; 1997 May; 10(5):600-8. PubMed ID: 9168259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism-based inactivation of rat liver cytochrome P-450 2B1 by 2-methoxy-5-nitrobenzyl bromide.
    Armstrong AP; Hollenberg PF
    Drug Metab Dispos; 1999 Jun; 27(6):741-5. PubMed ID: 10348806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inactivation of cytochrome P450 2E1 by benzyl isothiocyanate.
    Moreno RL; Kent UM; Hodge K; Hollenberg PF
    Chem Res Toxicol; 1999 Jul; 12(7):582-7. PubMed ID: 10409397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mechanism of inhibition by chlorgyline and deprenyl of tyramine deamination by mitochondrial monoamine oxidase of rat liver].
    Deverina IS
    Biokhimiia; 1980 Oct; 45(10):1897-908. PubMed ID: 6786369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of metabolism dependent inhibition of CYP2B6 mediated bupropion hydroxylation in human liver microsomes by monoamine oxidase inhibitors and prediction of potential as perpetrators of drug interaction.
    Nirogi R; Palacharla RC; Mohammed AR; Manoharan A; Ponnamaneni RK; Bhyrapuneni G
    Chem Biol Interact; 2015 Mar; 230():9-20. PubMed ID: 25656918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of protein denaturing reactions on retardation of the activity of rat liver mitochondrial monoamine oxidase by clorgyline and deprenyl].
    Severina IS
    Biokhimiia; 1983 Sep; 48(9):1513-21. PubMed ID: 6414536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
    Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N
    J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism-based inactivation of cytochromes P450 2E1 and 2B1 by 5-phenyl-1-pentyne.
    Roberts ES; Alworth WL; Hollenberg PF
    Arch Biochem Biophys; 1998 Jun; 354(2):295-302. PubMed ID: 9637739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of cytochrome P450 2E1 by tert-butylisothiocyanate.
    Kent UM; Roberts ES; Chun J; Hodge K; Juncaj J; Hollenberg PF
    Chem Res Toxicol; 1998 Oct; 11(10):1154-61. PubMed ID: 9778311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsomal oxidation of N,N-diethylformamide and its effect on P450-dependent monooxygenases in rat liver.
    Amato G; Longo V; Mazzaccaro A; Gervasi PG
    Chem Res Toxicol; 1996; 9(5):882-90. PubMed ID: 8828925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of benzyl isothiocyanate on rat and human cytochromes P450: identification of metabolites formed by P450 2B1.
    Goosen TC; Mills DE; Hollenberg PF
    J Pharmacol Exp Ther; 2001 Jan; 296(1):198-206. PubMed ID: 11123381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of cytochrome P450s 2B1, 2B4, 2B6, and 2B11 by arylalkynes.
    Roberts ES; Hopkins NE; Foroozesh M; Alworth WL; Halpert JR; Hollenberg PF
    Drug Metab Dispos; 1997 Nov; 25(11):1242-8. PubMed ID: 9351899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of rat brain cytosolic monoamine oxidase activity by clorgyline. Comparison with (-)-deprenyl and MDL 72145.
    Azam M; Jain S; Baquer NZ
    Biochem Pharmacol; 1990 Nov; 40(10):2215-8. PubMed ID: 2123104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.